756 related articles for article (PubMed ID: 12444207)
1. A role for uric acid in the progression of renal disease.
Kang DH; Nakagawa T; Feng L; Watanabe S; Han L; Mazzali M; Truong L; Harris R; Johnson RJ
J Am Soc Nephrol; 2002 Dec; 13(12):2888-97. PubMed ID: 12444207
[TBL] [Abstract][Full Text] [Related]
2. Mild hyperuricemia induces vasoconstriction and maintains glomerular hypertension in normal and remnant kidney rats.
Sánchez-Lozada LG; Tapia E; Santamaría J; Avila-Casado C; Soto V; Nepomuceno T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
Kidney Int; 2005 Jan; 67(1):237-47. PubMed ID: 15610247
[TBL] [Abstract][Full Text] [Related]
3. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.
Mazzali M; Kanellis J; Han L; Feng L; Xia YY; Chen Q; Kang DH; Gordon KL; Watanabe S; Nakagawa T; Lan HY; Johnson RJ
Am J Physiol Renal Physiol; 2002 Jun; 282(6):F991-7. PubMed ID: 11997315
[TBL] [Abstract][Full Text] [Related]
4. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism.
Mazzali M; Hughes J; Kim YG; Jefferson JA; Kang DH; Gordon KL; Lan HY; Kivlighn S; Johnson RJ
Hypertension; 2001 Nov; 38(5):1101-6. PubMed ID: 11711505
[TBL] [Abstract][Full Text] [Related]
5. Activation of ATP-sensitive potassium channels protects vascular endothelial cells from hypertension and renal injury induced by hyperuricemia.
Long CL; Qin XC; Pan ZY; Chen K; Zhang YF; Cui WY; Liu GS; Wang H
J Hypertens; 2008 Dec; 26(12):2326-38. PubMed ID: 19008712
[TBL] [Abstract][Full Text] [Related]
6. The impact of gender on progression of renal disease: potential role of estrogen-mediated vascular endothelial growth factor regulation and vascular protection.
Kang DH; Yu ES; Yoon KI; Johnson R
Am J Pathol; 2004 Feb; 164(2):679-88. PubMed ID: 14742271
[TBL] [Abstract][Full Text] [Related]
7. Hyperuricemia induces endothelial dysfunction.
Khosla UM; Zharikov S; Finch JL; Nakagawa T; Roncal C; Mu W; Krotova K; Block ER; Prabhakar S; Johnson RJ
Kidney Int; 2005 May; 67(5):1739-42. PubMed ID: 15840020
[TBL] [Abstract][Full Text] [Related]
8. Mild hyperuricemia induces glomerular hypertension in normal rats.
Sánchez-Lozada LG; Tapia E; Avila-Casado C; Soto V; Franco M; Santamaría J; Nakagawa T; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
Am J Physiol Renal Physiol; 2002 Nov; 283(5):F1105-10. PubMed ID: 12372787
[TBL] [Abstract][Full Text] [Related]
9. Uric acid: bystander or culprit in hypertension and progressive renal disease?
Menè P; Punzo G
J Hypertens; 2008 Nov; 26(11):2085-92. PubMed ID: 18854744
[TBL] [Abstract][Full Text] [Related]
10. Uric acid--a uremic toxin?
Nakagawa T; Mazzali M; Kang DH; Sánchez-Lozada LG; Herrera-Acosta J; Johnson RJ
Blood Purif; 2006; 24(1):67-70. PubMed ID: 16361844
[TBL] [Abstract][Full Text] [Related]
11. Uric acid and chronic renal disease: possible implication of hyperuricemia on progression of renal disease.
Kang DH; Nakagawa T
Semin Nephrol; 2005 Jan; 25(1):43-9. PubMed ID: 15660334
[TBL] [Abstract][Full Text] [Related]
12. Hemodynamics of hyperuricemia.
Sánchez-Lozada LG; Tapia E; Rodríguez-Iturbe B; Johnson RJ; Herrera-Acosta J
Semin Nephrol; 2005 Jan; 25(1):19-24. PubMed ID: 15660330
[TBL] [Abstract][Full Text] [Related]
13. Hyperuricemia causes glomerular hypertrophy in the rat.
Nakagawa T; Mazzali M; Kang DH; Kanellis J; Watanabe S; Sanchez-Lozada LG; Rodriguez-Iturbe B; Herrera-Acosta J; Johnson RJ
Am J Nephrol; 2003; 23(1):2-7. PubMed ID: 12373074
[TBL] [Abstract][Full Text] [Related]
14. Oxonic acid-induced hyperuricemia elevates plasma aldosterone in experimental renal insufficiency.
Eräranta A; Kurra V; Tahvanainen AM; Vehmas TI; Kööbi P; Lakkisto P; Tikkanen I; Niemelä OJ; Mustonen JT; Pörsti IH
J Hypertens; 2008 Aug; 26(8):1661-8. PubMed ID: 18622246
[TBL] [Abstract][Full Text] [Related]
15. Use of allopurinol in slowing the progression of renal disease through its ability to lower serum uric acid level.
Siu YP; Leung KT; Tong MK; Kwan TH
Am J Kidney Dis; 2006 Jan; 47(1):51-9. PubMed ID: 16377385
[TBL] [Abstract][Full Text] [Related]
16. Uric acid increases fibronectin synthesis through upregulation of lysyl oxidase expression in rat renal tubular epithelial cells.
Yang Z; Xiaohua W; Lei J; Ruoyun T; Mingxia X; Weichun H; Li F; Ping W; Junwei Y
Am J Physiol Renal Physiol; 2010 Aug; 299(2):F336-46. PubMed ID: 20484295
[TBL] [Abstract][Full Text] [Related]
17. Cardio-renal protective effect of the xanthine oxidase inhibitor febuxostat in the 5/6 nephrectomy model with hyperuricemia.
Omizo H; Tamura Y; Morimoto C; Ueno M; Hayama Y; Kuribayashi-Okuma E; Uchida S; Shibata S
Sci Rep; 2020 Jun; 10(1):9326. PubMed ID: 32518351
[TBL] [Abstract][Full Text] [Related]
18. [Role of uric acid in hypertension and in the progression of chronic renal disease].
Barberi S; Menè P
G Ital Nefrol; 2006; 23(1):4-11. PubMed ID: 16521070
[TBL] [Abstract][Full Text] [Related]
19. Treatment with the xanthine oxidase inhibitor febuxostat lowers uric acid and alleviates systemic and glomerular hypertension in experimental hyperuricaemia.
Sánchez-Lozada LG; Tapia E; Soto V; Avila-Casado C; Franco M; Zhao L; Johnson RJ
Nephrol Dial Transplant; 2008 Apr; 23(4):1179-85. PubMed ID: 18048425
[TBL] [Abstract][Full Text] [Related]
20. Effect of elevated serum uric acid on cisplatin-induced acute renal failure.
Roncal CA; Mu W; Croker B; Reungjui S; Ouyang X; Tabah-Fisch I; Johnson RJ; Ejaz AA
Am J Physiol Renal Physiol; 2007 Jan; 292(1):F116-22. PubMed ID: 17210794
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
